Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sleep-disordered breathing in multiple sclerosis.
Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis.
Melatonin Lulling Th17 Cells to Sleep.
A Case Report of Post Rabipur (Purified Chick Embryo Rabies Vaccine) Acute Disseminated Encephalomyelitis.
Intermediate uveitis and multiple sclerosis: to scan or not to scan.
Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene.
Recurrent Optic Neuritis in Children.
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Advances of Molecular Imaging for Monitoring the Anatomical and Functional Architecture of the Olfactory System.
MRI in the Evaluation of Acute Visual Syndromes.
Mouse CD11b+Gr-1+ Myeloid Cells Can Promote Th17 Cell Differentiation and Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.
Experimental models of neuromyelitis optica: current status, challenges and future directions.
Aquaporin-4 autoimmunity.
White matter disease: 'Bright spotty lesions'-a novel NMO-specific MRI feature?
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients.
Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.
Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm.
Political notebook.
Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements.
The Relationship Between Quality of Life and Dysarthria in Patients with Mutliple Sclerosis.
Pages
« first
‹ previous
…
453
454
455
456
457
458
459
460
461
…
next ›
last »